| Financial Year |
March 31 2023 |
| Monetary Funds |
233,531,436.72 |
| Held-for-trading Financial Assets |
449,308,635.02 |
| Notes Receivable |
11,081,194.03 |
| Accounts Receivable |
681,250,794.71 |
| Advances to Suppliers |
35,460,516.80 |
| Other Receivables |
100,769,094.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,548.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,849,191.02 |
| Other Current Assets |
8,329,881.50 |
| Total Current Assets |
1,890,507,317.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,127,809.05 |
| Long-term Equity Investment |
66,854,539.62 |
| Investment Properties |
57,306,946.87 |
| Fixed Assetes |
387,466,184.10 |
| Under-construction Projects |
72,493,342.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
232,599,610.06 |
| R&D expenses |
-- |
| Goodwill |
208,370,930.54 |
| Long-Term Deferred and Prepaid Expenses |
6,648,247.47 |
| Deferred Income Tax Assets |
38,447,362.83 |
| Other Non-Current Assets |
66,314,927.51 |
| Sub-Total of Non-Current Assets |
1,320,072,313.15 |
| Total Assets |
3,210,579,630.59 |
| Short-Term Loans |
307,130,325.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,676,604.85 |
| Accounts Payable |
783,028,677.62 |
| Accounts Received In Advance |
1,141,572.24 |
| Employee Compensation Payable |
120,800,605.64 |
| Taxes Payable |
22,693,269.24 |
| Interest Payable |
-- |
| Dividend Payable |
22,825,489.94 |
| Other payables |
103,321,678.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,009,514.50 |
| Other Current Liabilities |
28,192,830.55 |
| Sub-Total of Current Liabilities |
1,664,025,060.77 |
| Long-term Loans |
34,652,760.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,468,973.30 |
| Deferred Income Tax Liabilities |
6,610,435.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,762,339.66 |
| Total Liabilities |
1,738,787,400.43 |
| Paid-In Capital(Or Share Stock) |
275,905,778.00 |
| Capital Surplus |
1,005,480,991.39 |
| Surplus Reserve |
119,740,851.67 |
| LESS:Treasury Stock |
49,493,429.60 |
| Undistributed Profits |
90,111,704.07 |
| Minority Stockholder's Interest |
29,915,289.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,441,876,940.77 |
| Owner's Equity（Stockholder's Equity） |
1,471,792,230.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,210,579,630.59 |
